CS logo
small CS logo
Instituto de Ensino e Pesquisa do Hospital da Bahia

Salvador, Bahia, Brazil

About Instituto de Ensino e Pesquisa do Hospital da Bahia


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
2
Amgen
1
Brazilian Clinical Research Institute
1
Total Rows: 3

Clinical Trials at Instituto de Ensino e Pesquisa do Hospital da Bahia


During the past decade, Instituto de Ensino e Pesquisa do Hospital da Bahia conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years220011001100Started TrialsCompleted Trails2020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
GLORIA-AF Registry Program - Second and Third Phases
2011-11-07
2020-01-10
Completed
37,235
Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial
2020-06-21
2021-05-30
Completed
615
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)
2020-12-16
2023-08-31
Active, not recruiting
6,522
A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)
2022-04-19
2024-01-05
Recruiting
40,000

Rows per page:

1–4 of 4

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Ensino e Pesquisa do Hospital da Bahia" #1 collaborator was "Beneficência Portuguesa de São Paulo" with 1 trials as a collaborator, "Brazilian Research In Intensive Care Network" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Hospital Alemão Oswaldo Cruz" with 1 trials as a collaborator and "Hospital Israelita Albert Einstein" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 2Boehringer Ingelheim: 2Amgen: 1Amgen: 1Brazilian ClinicalResearch Institute: 1Brazilian ClinicalResearch Institute: 1

Created with Highcharts 11.1.0Top CollaboratorsBeneficênciaPortuguesa de SãoPaulo: 1BeneficênciaPortuguesa de SãoPaulo: 1Brazilian Research InIntensive Care Network:1Brazilian Research InIntensive Care Network:1Eli Lilly and Company: 1Eli Lilly and Company: 1Hospital AlemãoOswaldo Cruz: 1Hospital AlemãoOswaldo Cruz: 1Hospital Israelita AlbertEinstein: 1Hospital Israelita AlbertEinstein: 1Hospital Moinhos de Vento: 1Hospital Moinhos de Vento: 1Hospital Sirio-Libanes: 1Hospital Sirio-Libanes: 1Hospital do Coracao: 1Hospital do Coracao: 1

Clinical Trials Conditions at Instituto de Ensino e Pesquisa do Hospital da Bahia


According to Clinical.Site data, the most researched conditions in "Instituto de Ensino e Pesquisa do Hospital da Bahia" are "Atherosclerotic Cardiovascular Disease" (1 trials), "Atrial Fibrillation" (1 trials), "Coronavirus Infection" (1 trials), "Myocardial Infarction" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Instituto de Ensino e Pesquisa do Hospital da Bahia" in a lesser frequency.

Clinical Trials Intervention Types at Instituto de Ensino e Pesquisa do Hospital da Bahia


Most popular intervention types in "Instituto de Ensino e Pesquisa do Hospital da Bahia" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Empagliflozin" (1 trials), "Group 1: Rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed" (1 trials), "Group 2: control group with enoxaparin 40mg/d" (1 trials), "Lp(a) Screening" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Instituto de Ensino e Pesquisa do Hospital da Bahia


The vast majority of trials in "Instituto de Ensino e Pesquisa do Hospital da Bahia" are 4 trials for "All" genders.

Clinical Trials Status at Instituto de Ensino e Pesquisa do Hospital da Bahia


Currently, there are NaN active trials in "Instituto de Ensino e Pesquisa do Hospital da Bahia". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Instituto de Ensino e Pesquisa do Hospital da Bahia, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Instituto de Ensino e Pesquisa do Hospital da Bahia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhaseNot Applicable: 1Not Applicable: 1Phase 3: 1Phase 3: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 2Completed: 2Active, not recruiting: 1Active, not recruiting: 1Recruiting: 1Recruiting: 1